Meeting
2019 Genitourinary Cancers Symposium
Predictors of prostate bed nodule on MRI in patients with rising PSA after radical prostatectomy.
Authors
Nicola Joseph Nasser
Montefiore Medical Center, Bronx, NY
Nicola Joseph Nasser , Victoria Chernyak , Shalom Kalnicki , Jonathan Klein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 122)
DOI
10.1200/JCO.2019.37.7_suppl.122
Abstract #
122
Poster Bd #
C4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of MRI and targeted biopsy on oncological outcomes of prostate cancer after treatment.
First Author: Neha Debnath
Poster
2022 ASCO Genitourinary Cancers Symposium
Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.
First Author: Markus Grabbert
Poster
2022 ASCO Genitourinary Cancers Symposium
Early initiation of salvage radiotherapy is associated with improved metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.
First Author: Emerson Lee
Poster
2019 ASCO Annual Meeting
Prospective head-to-head comparative phase 3 study between 18F-fluciclovine and 68Ga-PSMA-11 PET/CT in patients with early biochemical recurrence of prostate cancer.
First Author: Jeremie Calais